CCDC69 and ovarian carcinoma: Cui et al. revealed that CCDC69 could enhance platinum-induced apoptosis in ovarian cancer [10], and they further verified that the overexpression of CCDC69 could activate p14ARF/MDM2/p53 pathway and confer cisplatin sensitivity [15].